NEW YORK (GenomeWeb) – Illumina today priced its $1 billion convertible senior notes offering, which it expects will bring in net proceeds of approximately $985 million.

The $1 billion in senior notes is above the $900 million that the firm proposed on Wednesday when it initially announced the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."